The stock looks good here. TA + Fundamentals. 1) Vivani Medical wants to bring a subdermal drug delivery implant to the diabetes market 2) Vivani Medical Announces Public Filing of Registration Statement for the Proposed Initial Public Offering of Cortigent, Inc., a Subsidiary Advancing the Business of its Neuromodulation Division. 3) Notable Insider Transactions: - Insider Purchase reported in Vivani Medical, a biopharmaceutical company developing miniaturized, long-term drug implants, for the treatment of patients with type 2 diabetes. Chairman, Gregg Williams, purchased 2.2M of #VivaniMedical shares NASDAQ:VANI